Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by OttawaPeteron Jan 25, 2023 11:13am
111 Views
Post# 35245181

RE:Voting Down The Midatech Deal

RE:Voting Down The Midatech Deal

Boomskid wrote:
 It should be noted that the Midatech deal remains on the AGM agenda. Voting it up or down can still take place, even though the vote will not directly change things.
 
If the deal is not specifically voted down, DrDR may try to make the case that because the Bioasis shareholders approved it and if the Midatech shareholders had not voted it down then the deal would have gone through.
 
So, unless the Midatech is specifically voted down, DrDR may make the case that the door remains open for such a deal, that it could because the shareholders approved the old deal.
 
I think shareholders ought to vote on this even though it cannot mean that the old deal can go through. DrDR has a practice of squeezing all meaning she can from some things, and yet avoiding the meaning of other things, whichever suits her own judgement or agenda.

Has the Bioasis/Midatech-corporate presentation been left on the Bioasis website on purpose?
 
jd
 
 

Good point! Vote NO.

<< Previous
Bullboard Posts
Next >>